hydrocodone polistirex and chlorpheniramine polistirex extended-release
Generic: hydrocodone polistirex and chlorpheniramine polistirex
Labeler: cranbury pharmaceuticals, llcDrug Facts
Product Profile
Brand Name
hydrocodone polistirex and chlorpheniramine polistirex extended-release
Generic Name
hydrocodone polistirex and chlorpheniramine polistirex
Labeler
cranbury pharmaceuticals, llc
Dosage Form
SUSPENSION, EXTENDED RELEASE
Routes
Active Ingredients
chlorpheniramine maleate 8 mg/5mL, hydrocodone bitartrate 10 mg/5mL
Manufacturer
Identifiers & Regulatory
Product NDC
27808-086
Product ID
27808-086_b3ac95d4-bef9-4e32-9822-73b9534c9869
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA091632
DEA Schedule
cii
Listing Expiration
2027-12-31
Marketing Start
2015-03-06
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
27808086
Hyphenated Format
27808-086
Supplemental Identifiers
RxCUI
UPC
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
hydrocodone polistirex and chlorpheniramine polistirex extended-release (source: ndc)
Generic Name
hydrocodone polistirex and chlorpheniramine polistirex (source: ndc)
Application Number
ANDA091632 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 8 mg/5mL
- 10 mg/5mL
Packaging
- 1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-086-01) / 115 mL in 1 BOTTLE, UNIT-DOSE
- 473 mL in 1 BOTTLE (27808-086-02)
Packages (2)
Ingredients (2)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "b3ac95d4-bef9-4e32-9822-73b9534c9869", "openfda": {"upc": ["0327808086013"], "unii": ["V1Q0O9OJ9Z", "NO70W886KK"], "rxcui": ["1087459"], "spl_set_id": ["25f400d9-1d6e-4d38-8f0d-98d471eba73b"], "manufacturer_name": ["Cranbury Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, UNIT-DOSE in 1 CARTON (27808-086-01) / 115 mL in 1 BOTTLE, UNIT-DOSE", "package_ndc": "27808-086-01", "marketing_start_date": "20150306"}, {"sample": false, "description": "473 mL in 1 BOTTLE (27808-086-02)", "package_ndc": "27808-086-02", "marketing_start_date": "20150306"}], "brand_name": "Hydrocodone Polistirex and Chlorpheniramine Polistirex extended-release", "product_id": "27808-086_b3ac95d4-bef9-4e32-9822-73b9534c9869", "dosage_form": "SUSPENSION, EXTENDED RELEASE", "pharm_class": ["Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Opioid Agonist [EPC]", "Opioid Agonists [MoA]"], "product_ndc": "27808-086", "dea_schedule": "CII", "generic_name": "Hydrocodone Polistirex and Chlorpheniramine Polistirex", "labeler_name": "Cranbury Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Hydrocodone Polistirex and Chlorpheniramine Polistirex", "brand_name_suffix": "extended-release", "active_ingredients": [{"name": "CHLORPHENIRAMINE MALEATE", "strength": "8 mg/5mL"}, {"name": "HYDROCODONE BITARTRATE", "strength": "10 mg/5mL"}], "application_number": "ANDA091632", "marketing_category": "ANDA", "marketing_start_date": "20150306", "listing_expiration_date": "20271231"}